Absci Corporation (ABSI) Stock Grade

About Absci Corporation's fundamentals

Absci Corporation is a biotechnology company with a market capitalization of $477.4 million that reported a significant net loss in its latest annual statement, resulting in a net margin of -4113.7%. The company experienced substantial revenue contraction, declining 38.2% year-over-year, indicating shrinking sales despite its position in the healthcare sector. The company does not pay a dividend and lacks meaningful profitability metrics such as a positive P/E ratio or return on equity, reflecting its current unprofitable operational status.